3,4,3',4'-tetrachlorobiphenyl has been researched along with promegestone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, MS; McDougal, A; Ramamoorthy, K; Safe, SH; Sun, G | 1 |
1 other study(ies) available for 3,4,3',4'-tetrachlorobiphenyl and promegestone
| Article | Year |
|---|---|
3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Binding, Competitive; Breast Neoplasms; Cell Division; Estradiol; Estrogen Antagonists; Estrogens; Female; Gene Expression Regulation; Genes, Reporter; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasms, Hormone-Dependent; Organ Size; Peroxidases; Polychlorinated Biphenyls; Promegestone; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured; Uterus | 1999 |